PureTech Health plc (PRTC) Receivables (2019 - 2024)
PureTech Health (PRTC) has disclosed Receivables for 3 consecutive years, with $450000.0 as the latest value for Q4 2022.
- On a quarterly basis, Receivables fell 87.46% to $450000.0 in Q4 2022 year-over-year; TTM through Dec 2022 was $450000.0, a 87.46% decrease, with the full-year FY2022 number at $450000.0, down 87.46% from a year prior.
- Receivables was $450000.0 for Q4 2022 at PureTech Health, down from $3.6 million in the prior quarter.
- In the past five years, Receivables ranged from a high of $3.6 million in Q4 2021 to a low of $450000.0 in Q4 2022.
- A 3-year average of $2.3 million and a median of $2.9 million in 2020 define the central range for Receivables.
- Peak YoY movement for Receivables: increased 22.12% in 2021, then tumbled 87.46% in 2022.
- PureTech Health's Receivables stood at $2.9 million in 2020, then increased by 22.12% to $3.6 million in 2021, then crashed by 87.46% to $450000.0 in 2022.
- Per Business Quant, the three most recent readings for PRTC's Receivables are $450000.0 (Q4 2022), $3.6 million (Q4 2021), and $2.9 million (Q4 2020).